Related references
Note: Only part of the references are listed.Systemic treatment for lung carcinoids: from bench to bedside
Mariangela Torniai et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Combining chloroquine with RAD001 inhibits tumor growth in a NEN mouse model
Shani Avniel-Polak et al.
ENDOCRINE-RELATED CANCER (2018)
Monitoring and Measuring Autophagy
Saori R. Yoshii et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells
Shani Avniel-Polak et al.
NEUROENDOCRINOLOGY (2016)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Tumor Vessel Normalization by Chloroquine Independent of Autophagy
Hannelore Maes et al.
CANCER CELL (2014)
Chloroquine Targets Pancreatic Cancer Stem Cells via Inhibition of CXCR4 and Hedgehog Signaling
Anamaria Balic et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Improvement of ER stress-induced diabetes by stimulating autophagy
Etty Bachar-Wikstrom et al.
AUTOPHAGY (2013)
PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors
Edward M. Wolin
CANCER LETTERS (2013)
Autophagy sensitivity of neuroendocrine lung tumor cells
Seung-Keun Hong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [177Lu-DOTA0,Tyr3]Octreotate
Esther I. van Vliet et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence
Anna Grimaldi et al.
PLOS ONE (2013)
Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas
Do-Youn Oh et al.
CANCER (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Autophagy modulation as a potential therapeutic target for diverse diseases
David C. Rubinsztein et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The Role of Autophagy in Cancer: Therapeutic Implications
Zhineng J. Yang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung
Luisella Righi et al.
ENDOCRINE-RELATED CANCER (2010)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Molecular cloning and characterization of rat LC3A and LC3B -: Two novel markers of autophagosome
JX Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes
I Tanida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Y Kabeya et al.
JOURNAL OF CELL SCIENCE (2004)
Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B
H He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A ubiquitin-like system mediates protein lipidation
Y Ichimura et al.
NATURE (2000)
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing
Y Kabeya et al.
EMBO JOURNAL (2000)
Share Paper
